Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Difamilast in Dermatitis, Atopic: NCT07173478 Clinical Landscape Report 2026
15 October 2026
NCT07173478 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ALE.P03 in Intrahepatic Cholangiocarcinoma: NCT07169734 Clinical Landscape Report 2026
15 October 2026
NCT07169734 clinical landscape for Intrahepatic Cholangiocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PF-08049820 in Dermatitis, Atopic: NCT07172321 Clinical Landscape Report 2026
15 October 2026
NCT07172321 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Disitamab Vedotin in Recurrent Cervical Cancer: NCT07172217 Clinical Landscape Report 2026
15 October 2026
NCT07172217 clinical landscape for Recurrent Cervical Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ascorbic Acid in Acute Myeloid Leukemia: NCT07177079 Clinical Landscape Report 2026
15 October 2026
NCT07177079 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BZE-2204 in Idiopathic Inflammatory Myopathies: NCT07174843 Clinical Landscape Report 2026
15 October 2026
NCT07174843 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
SIM-0278 in Dermatitis, Atopic: NCT07175233 Clinical Landscape Report 2026
15 October 2026
NCT07175233 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
AL58805 in Lung Cancer: NCT07179081 Clinical Landscape Report 2026
15 October 2026
NCT07179081 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zamtocabtagene autoleucel in Multiple Sclerosis, Primary Progressive: NCT07178431 Clinical Landscape Report 2026
15 October 2026
NCT07178431 clinical landscape for Multiple Sclerosis, Primary Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
LB-4330 in Human Papillomavirus-Related Cervical Adenocarcinoma In Situ: NCT07177716 Clinical Landscape Report 2026
15 October 2026
NCT07177716 clinical landscape for Human Papillomavirus-Related Cervical Adenocarcinoma In Situ: endpoints, sponsor, phase, geography, readouts, asset contex…
9 min read
Ocrelizumab in Fatigue: NCT07181811 Clinical Landscape Report 2026
15 October 2026
NCT07181811 clinical landscape for Fatigue: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Drospirenone/Ethinyl Estradiol in Psoriasis of scalp: NCT07181343 Clinical Landscape Report 2026
15 October 2026
NCT07181343 clinical landscape for Psoriasis of scalp: endpoints, sponsor, phase, geography, readouts, asset context and development white space.